Skip to main content

Balboa Wealth Partners

Position in NVO — Novo Nordisk A S

CIK 1929008 SCOTTSDALE, AZ

Position in NVO

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$740,720
+$250,733 QoQ
Shares Held
15,451
+15.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#600
of 1,348 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Balboa Wealth Partners holds $9,778,849 across 9 Drug Manufacturers - General names. NVO ranks #5 (7.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVO
Novo Nordisk A S
This page
15,451 $740,720

All Filings in NVO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $740,720 15,451
2026-03-31 $489,987 13,333
2025-12-31 $605,522 11,901
2025-09-30 $661,052 11,913
2025-06-30 $807,188 11,695
2025-03-31 $765,089 11,018
2024-12-31 $924,284 10,745
2024-09-30 $235,877 1,981
2024-06-30 $343,717 2,408
2024-03-31 $350,532 2,730
2023-12-31 $385,971 3,731
2023-09-30 $208,525 2,293
2023-03-31 $216,112 1,358